More interestingly, HA specifically binds to CD44 and improves intracellular anticancer drug delivery to various cancerous cells, including breast cancer cells; therefore, HA-containing systems can act as favorable anticancer drug carriers for effective chemotherapy [14,18,22,[24], [25], [26], [27]]. Here, CD44 is linked to breast carcinoma.